Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Clinical and Experimental Hepatology
|
March 17, 2025
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and Subgroups
Laurens A van Kleef, Jesse Pustjens, Harry L A Janssen, et al.
World Journal of Gastroenterology
|
September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations
Jesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
JHEP Reports : Innovation in Hepatology
|
December 6, 2024
Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD
Jesse Pustjens, Laurens A van Kleef, Harry L A Janssen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 25, 2025
FIB-4-based Referral Pathways Have Suboptimal Accuracy to identify Increased Liver Stiffness and Incident Advanced Liver Disease
Laurens A van Kleef, Rickard Strandberg, Jesse Pustjens, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 31, 2025
Young Adults Are at Highest Risk of Liver Fibrosis and Mortality Associated With Steatotic Liver Disease With Metabolic Dysfunction and Alcohol Consumption
Jesse Pustjens, Laurens A van Kleef, Zobair M Younossi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 22, 2024
MASLD, At-Risk MASH and Increased Liver Stiffness Are Associated With Young Adulthood Obesity Without Residual Risk After Losing Obesity
Laurens A van Kleef, Jesse Pustjens, Mesut Savas, et al.
Gastro Hep Advances
|
December 4, 2025
Weight Change is Associated With Metabolic Liver Health in a General Population Extending Beyond Weight Loss Targets of International Guidelines
Laurens A van Kleef, Mesut Savas, Maurice Michel, et al.
The American Journal of Gastroenterology
|
July 23, 2025
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting
Laurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Hepatology (Baltimore, Md.)
|
May 7, 2025
Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction
Laurens A van Kleef, Jesse Pustjens, Jörn M Schattenberg, et al.
Gastro Hep Advances
|
April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population
Laurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Clinical and Experimental Hepatology
|
March 17, 2025
Diagnostic Accuracy of the LiverRisk Score to Detect Increased Liver Stiffness Among a United States General Population and Subgroups
Laurens A van Kleef, Jesse Pustjens, Harry L A Janssen, et al.
World Journal of Gastroenterology
|
September 30, 2025
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations
Jesse Pustjens, Willem P Brouwer, Ibrahim Ayada, et al.
JHEP Reports : Innovation in Hepatology
|
December 6, 2024
Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD
Jesse Pustjens, Laurens A van Kleef, Harry L A Janssen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 25, 2025
FIB-4-based Referral Pathways Have Suboptimal Accuracy to identify Increased Liver Stiffness and Incident Advanced Liver Disease
Laurens A van Kleef, Rickard Strandberg, Jesse Pustjens, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 31, 2025
Young Adults Are at Highest Risk of Liver Fibrosis and Mortality Associated With Steatotic Liver Disease With Metabolic Dysfunction and Alcohol Consumption
Jesse Pustjens, Laurens A van Kleef, Zobair M Younossi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 22, 2024
MASLD, At-Risk MASH and Increased Liver Stiffness Are Associated With Young Adulthood Obesity Without Residual Risk After Losing Obesity
Laurens A van Kleef, Jesse Pustjens, Mesut Savas, et al.
Gastro Hep Advances
|
December 4, 2025
Weight Change is Associated With Metabolic Liver Health in a General Population Extending Beyond Weight Loss Targets of International Guidelines
Laurens A van Kleef, Mesut Savas, Maurice Michel, et al.
The American Journal of Gastroenterology
|
July 23, 2025
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting
Laurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Hepatology (Baltimore, Md.)
|
May 7, 2025
Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction
Laurens A van Kleef, Jesse Pustjens, Jörn M Schattenberg, et al.
Gastro Hep Advances
|
April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population
Laurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Page
of 2